Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective.
- DOI
- 10.1016/j.breast.2016.12.002
- Published
- 2017 Apr
- Container
- Breast (Edinburgh, Scotland)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2016.12.002,
title = {Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective.},
author = {Marchetti P and Maass N and Gligorov J and Berger K and MacDougall F and Montonen J and Lewis J},
year = {2017},
journal = {Breast (Edinburgh, Scotland)},
doi = {10.1016/j.breast.2016.12.002},
url = {https://doi.org/10.1016/j.breast.2016.12.002}
}RIS
TY - JOUR TI - Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective. AU - Marchetti P AU - Maass N AU - Gligorov J AU - Berger K AU - MacDougall F AU - Montonen J AU - Lewis J PY - 2017 JO - Breast (Edinburgh, Scotland) DO - 10.1016/j.breast.2016.12.002 UR - https://doi.org/10.1016/j.breast.2016.12.002 ER -
APA
P, M., N, M., J, G., K, B., F, M., J, M., & J, L. (2017). Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2016.12.002
Source records
- pubmed · retrieved 2026-09-25T09:03:45.807Z